|
US4018799A
(en)
|
1973-11-19 |
1977-04-19 |
Hoffmann-La Roche Inc. |
Antioxidant chroman compounds
|
|
US4026907A
(en)
|
1973-11-19 |
1977-05-31 |
Hoffmann-La Roche Inc. |
Antioxidant chroman compounds
|
|
JPS5640651A
(en)
|
1979-09-12 |
1981-04-16 |
Takeda Chem Ind Ltd |
Quinone compound and its preparation
|
|
US5272180A
(en)
|
1987-07-29 |
1993-12-21 |
Takeda Chemical Industries, Ltd. |
Cell proliferation inhibitor
|
|
US5348973A
(en)
|
1990-10-09 |
1994-09-20 |
Rhone-Poulenc Chimie |
Resolution of hydroxychroman-2-carboxylic acid esters by enantiomeric hydrolysis
|
|
US6150402A
(en)
|
1994-08-15 |
2000-11-21 |
Loma Linda University Medical Center |
Natriuretic compounds
|
|
SK282144B6
(sk)
|
1994-12-28 |
2001-11-06 |
Janssen Pharmaceutica N. V. |
Liečivo na terapeutické a profylaktické ošetrenie degeneratívnych chorôb vaskulárneho systému a nervovej sústavy, ktoré súvisia s oxidačným stresom
|
|
AU6709896A
(en)
|
1995-08-21 |
1997-03-12 |
Takeda Chemical Industries Ltd. |
Quinone compound, its production and use
|
|
US6232060B1
(en)
|
1996-01-19 |
2001-05-15 |
Galileo Laboratories, Inc. |
Assay system for anti-stress agents
|
|
US5801159A
(en)
|
1996-02-23 |
1998-09-01 |
Galileo Laboratories, Inc. |
Method and composition for inhibiting cellular irreversible changes due to stress
|
|
DE69712888D1
(de)
|
1996-07-11 |
2002-07-04 |
Takeda Chemical Industries Ltd |
ZUSAMMENSTELLUNGEN DIE beta-AMYLOID PROTEIN BEDINGTE ZYTOTOXIZITÄT VERHINDERN
|
|
US5821247A
(en)
|
1996-09-19 |
1998-10-13 |
Japan Energy Corporation |
Hydroquinone derivative and pharmaceutical use thereof
|
|
JP3093170B2
(ja)
*
|
1996-09-19 |
2000-10-03 |
株式会社ジャパンエナジー |
ヒドロキノン誘導体及びその医薬用途
|
|
JP3913329B2
(ja)
*
|
1997-09-11 |
2007-05-09 |
株式会社クラレ |
（±）−クロマンカルボン酸の光学分割法
|
|
FR2783519B1
(fr)
|
1998-09-23 |
2003-01-24 |
Sod Conseils Rech Applic |
Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
|
|
WO2000078296A2
(en)
|
1999-06-17 |
2000-12-28 |
Basf Aktiengesellschaft |
Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders
|
|
US6426362B1
(en)
|
1999-10-08 |
2002-07-30 |
Galileo Laboratories, Inc. |
Formulations of tocopherols and methods of making and using them
|
|
US6528042B1
(en)
|
1999-10-08 |
2003-03-04 |
Galileo Laboratories, Inc. |
Compositions of flavonoids for use as cytoprotectants and methods of making and using them
|
|
WO2002012221A1
(en)
|
2000-08-03 |
2002-02-14 |
Kuraray Co., Ltd. |
Method for optical resolution of (±)-6-hydroxy-2,5,7,8-tetramethylcoumarone-2-carboxylic acid
|
|
US7034054B2
(en)
|
2000-12-15 |
2006-04-25 |
Galileo Pharmaceuticals, Inc. |
Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
|
|
WO2002047680A2
(en)
|
2000-12-15 |
2002-06-20 |
Galileo Laboratories, Inc. |
Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia
|
|
US6608196B2
(en)
|
2001-05-03 |
2003-08-19 |
Galileo Pharmaceuticals, Inc. |
Process for solid supported synthesis of pyruvate-derived compounds
|
|
NZ513547A
(en)
|
2001-08-13 |
2002-09-27 |
Antipodean Biotechnology Ltd |
Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone)
|
|
WO2003015494A2
(en)
|
2001-08-21 |
2003-02-27 |
Galileo Pharmaceuticals, Inc. |
Tocopherol enriched compositions and amelioration of inflammatory symptoms
|
|
AU2002352726A1
(en)
|
2001-11-15 |
2003-06-10 |
Galileo Laboratories, Inc. |
Formulations and methods for treatment or amelioration of inflammatory conditions
|
|
US6667330B2
(en)
|
2002-01-31 |
2003-12-23 |
Galileo Pharmaceuticals, Inc. |
Furanone derivatives
|
|
US6653346B1
(en)
|
2002-02-07 |
2003-11-25 |
Galileo Pharmaceuticals, Inc. |
Cytoprotective benzofuran derivatives
|
|
US7078541B2
(en)
|
2002-02-07 |
2006-07-18 |
Galileo Pharmaceuticals, Inc. |
Benzofuran derivatives
|
|
GB0204232D0
(en)
|
2002-02-22 |
2002-04-10 |
Isis Innovation |
Assay
|
|
DE60211875T2
(de)
|
2002-07-01 |
2006-10-26 |
Santhera Pharmaceuticals (Schweiz) Ag |
Screeningverfahren und Verbindungen zur Behandlung von Friedreich ataxia
|
|
JP4599292B2
(ja)
|
2002-10-30 |
2010-12-15 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
物理的−化学的特性に基づく治療用化合物の同定
|
|
EP1454627A1
(en)
|
2003-03-06 |
2004-09-08 |
MyoContract Ltd. |
Alpha-Keto carbonyl calpain inhibitors
|
|
WO2005033092A1
(en)
|
2003-09-19 |
2005-04-14 |
Galileo Pharmaceuticals, Inc. |
Chroman derivatives
|
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
|
FR2875803B1
(fr)
|
2004-09-24 |
2006-11-24 |
Catalys Sarl |
Preparation de composes phenol-amides a proprietes antioxydantes
|
|
EP2471530B1
(en)
|
2005-06-01 |
2017-01-11 |
Edison Pharmaceuticals, Inc. |
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
CA2622523C
(en)
|
2005-09-15 |
2014-02-18 |
Edison Pharmaceuticals, Inc. |
Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
WO2007095630A2
(en)
|
2006-02-15 |
2007-08-23 |
The Regents Of The University Of California |
New ubiquinone analogs and methods of use
|
|
US9278085B2
(en)
|
2006-02-22 |
2016-03-08 |
Edison Pharmaceuticals, Inc. |
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
EP2088144B1
(en)
*
|
2006-10-26 |
2011-12-28 |
Mitsubishi Gas Chemical Company, Inc. |
Method of producing s-(-)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid
|
|
WO2008086025A2
(en)
|
2007-01-10 |
2008-07-17 |
Edison Pharmaceuticals, Inc. |
Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity
|
|
WO2009061744A2
(en)
*
|
2007-11-06 |
2009-05-14 |
Edison Pharmaceuticals, Inc. |
4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
|
|
WO2009088572A2
(en)
|
2008-01-07 |
2009-07-16 |
Centocor, Inc. |
Method of treating erythropoietin hyporesponsive anemias
|
|
EA023618B1
(ru)
|
2008-01-08 |
2016-06-30 |
Эдисон Фармасьютикалз, Инк. |
Производные (гет)арил-п-хинона для лечения митохондриальных болезней
|
|
EP2262519A4
(en)
|
2008-03-05 |
2011-03-23 |
Edison Pharmaceuticals Inc |
TREATMENT OF HEARING AND BALANCING DISORDERS WITH REDOXACTIVE THERAPEUTICS
|
|
WO2009111576A2
(en)
|
2008-03-05 |
2009-09-11 |
Edison Pharmaceuticals, Inc. |
2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
|
|
CA2723621A1
(en)
|
2008-05-15 |
2009-11-19 |
Edison Pharmaceuticals, Inc |
Treatment of hearing and balance impairments using compounds having erythropoietin activity
|
|
WO2009143268A2
(en)
|
2008-05-22 |
2009-11-26 |
Edison Pharmaceuticals, Inc. |
Treatment of mitochondrial diseases with an erythropoietin mimetic
|
|
JP5266875B2
(ja)
|
2008-05-23 |
2013-08-21 |
三菱瓦斯化学株式会社 |
有機カルボン酸エステルからの光学活性有機カルボン酸の製造方法
|
|
WO2009158348A1
(en)
|
2008-06-25 |
2009-12-30 |
Edison Pharmaceuticals, Inc. |
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
|
|
WO2010005989A1
(en)
|
2008-07-09 |
2010-01-14 |
Edison Pharmaceuticals, Inc. |
Dermatological compositions with anti-aging and skin even-toning properties
|
|
US20100029784A1
(en)
|
2008-07-30 |
2010-02-04 |
Hinman Andrew W |
Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
|
|
WO2010014758A1
(en)
|
2008-07-30 |
2010-02-04 |
Edison Pharmaceuticals, Inc. |
Use of hydrogenated pyrido[4,3-b] indoles for the treatment of oxidative stress
|
|
EP2344142B1
(en)
|
2008-09-10 |
2024-06-26 |
PTC Therapeutics, Inc. |
Treatment of pervasive developmental disorders with redox-active therapeutics
|
|
EP2362726B1
(en)
|
2008-10-14 |
2018-08-08 |
Bioelectron Technology Corporation |
Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
|
|
CA2741767C
(en)
|
2008-10-28 |
2017-09-12 |
Ptc Therapeutics, Inc. |
Process for the production of alpha-tocotrienol and derivatives
|
|
PL2424495T3
(pl)
|
2009-04-28 |
2018-06-29 |
Bioelectron Technology Corporation |
Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
|
|
JP2012525397A
(ja)
|
2009-04-28 |
2012-10-22 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
眼科疾患を治療するためのトコトリエノールキノンの製剤
|
|
EP2424360A4
(en)
|
2009-04-28 |
2012-10-03 |
Ampere Life Sciences Inc |
TOPICAL, PERIOCULAR OR INTRAOCULAR USE OF TOCOTRIENOLS FOR THE TREATMENT OF OPHTHALMIC DISEASES
|
|
EP2609921A1
(en)
|
2009-06-25 |
2013-07-03 |
Ampere Life Sciences, Inc. |
Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts
|
|
DK2470168T3
(en)
|
2009-08-26 |
2018-05-07 |
Bioelectron Tech Corp |
PROCEDURES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCAM
|
|
WO2011041452A2
(en)
|
2009-10-01 |
2011-04-07 |
Ampere Life Sciences, Inc. |
Mouse model for identifying compounds for the treatment of oxidative stress
|
|
US20110172312A1
(en)
|
2009-12-31 |
2011-07-14 |
Miller Guy M |
Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
|
|
US8464722B2
(en)
|
2010-03-04 |
2013-06-18 |
Medline Industries, Inc. |
Folded telescopic equipment drape and method of folding and using the same
|
|
SG184787A1
(en)
|
2010-03-09 |
2012-11-29 |
Edison Pharmaceuticals Inc |
Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same
|
|
WO2011113018A1
(en)
|
2010-03-12 |
2011-09-15 |
Ampere Life Sciences, Inc. |
Measurement and control of biological time
|
|
AU2011238525A1
(en)
|
2010-04-06 |
2012-11-08 |
Edison Pharmaceuticals, Inc. |
Treatment of Ataxia Telangiectasia
|
|
CA2797581A1
(en)
|
2010-04-27 |
2011-11-03 |
Edison Pharmaceuticals, Inc. |
Formulations of quinones for the treatment of ophthalmic diseases
|
|
US20120101169A1
(en)
|
2010-07-14 |
2012-04-26 |
Penwest Pharmaceuticals Co. |
Methods of providing anticoagulation effects in subjects
|
|
EP2601168A4
(en)
|
2010-08-06 |
2013-12-04 |
Ampere Life Sciences Inc |
TREATMENT OF MITOCHONDRIAL DISEASES BY VITAMIN K
|
|
EA201300215A1
(ru)
|
2010-08-06 |
2013-07-30 |
Эдисон Фармасьютикалз, Инк. |
Лечение митохондриальных болезней нафтохинонами
|
|
WO2012068552A1
(en)
|
2010-11-19 |
2012-05-24 |
Edison Pharmaceuticals, Inc. |
Methods for improving blood glucose control
|
|
WO2012154613A1
(en)
|
2011-05-06 |
2012-11-15 |
Edison Pharmaceuticals, Inc. |
Improved process for the preparation of d-alpha-tocotrienol from natural extracts
|
|
WO2012170773A1
(en)
|
2011-06-08 |
2012-12-13 |
Edison Pharmaceuticals, Inc. |
Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
|
|
WO2012174286A1
(en)
|
2011-06-14 |
2012-12-20 |
Edison Pharmaceuticals, Inc. |
Catechol derivatives for treatment of oxidative stress diseases
|
|
WO2013006736A1
(en)
|
2011-07-06 |
2013-01-10 |
Edison Pharmaceuticals, Inc |
Treatment of leigh syndrome and leigh-like syndrome, including complications of sucla2 mutations, with tocotrienol quinones
|
|
US20150057363A1
(en)
|
2011-07-06 |
2015-02-26 |
Guy M. Miller |
Treatment of methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinones
|
|
JP2014520894A
(ja)
|
2011-07-19 |
2014-08-25 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
非アルファトコトリエノールの存在下でのアルファトコトリエノールの選択的酸化のための方法
|
|
CA2883879A1
(en)
|
2012-09-07 |
2014-03-13 |
Edison Pharmaceuticals, Inc. |
Quinone derivatives for use in the modulation of redox status of individuals
|
|
EA031098B1
(ru)
|
2013-03-08 |
2018-11-30 |
Юнилевер Н.В. |
Соединения резорцина для дерматологического применения
|
|
US9296712B2
(en)
|
2013-03-15 |
2016-03-29 |
Edison Pharmaceuticals, Inc. |
Resorufin derivatives for treatment of oxidative stress disorders
|
|
US20140275045A1
(en)
|
2013-03-15 |
2014-09-18 |
Edison Pharmaceuticals, Inc. |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US9868711B2
(en)
|
2013-03-15 |
2018-01-16 |
Bioelectron Technology Corporation |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US10189830B2
(en)
|
2013-03-15 |
2019-01-29 |
Bioelectron Technology Corporation |
Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
|
|
AU2014273891A1
(en)
|
2013-05-31 |
2015-12-24 |
Bioelectron Technology Corporation |
Carboxylic acid derivatives for treatment of oxidative stress disorders
|
|
US20180002247A1
(en)
|
2014-12-16 |
2018-01-04 |
Bioelectron Technology Corporation |
Methods for chiral resolution of trolox
|
|
AU2015364640B2
(en)
|
2014-12-16 |
2020-08-13 |
Ptc Therapeutics, Inc. |
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
|
|
WO2016114860A1
(en)
|
2015-01-12 |
2016-07-21 |
Edison Pharmaceuticals, Inc. |
Quinones for protection against radiation exposure
|
|
EP3390377B1
(en)
|
2015-12-16 |
2026-03-25 |
PTC Therapeutics, Inc. |
Improved methods for enriching alpha-tocotrienol from mixed tocol compositions
|
|
WO2017106803A1
(en)
|
2015-12-17 |
2017-06-22 |
Bioelectron Technology Corporation |
Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
|
|
WO2017123823A1
(en)
|
2016-01-12 |
2017-07-20 |
Bioelectron Technology Corporation |
Alkyl-, acyl-, urea-, and aza-uracil sulfide:quinone oxidoreductase inhibitors
|
|
JP2019501974A
(ja)
|
2016-01-12 |
2019-01-24 |
バイオエレクトロン テクノロジー コーポレイション |
チオスルフェートレベルを増加させるためのまたは硫化水素レベルを低下させるためのトコフェロールキノン誘導体およびトコトリエノールキノン誘導体
|
|
WO2018081644A1
(en)
|
2016-10-28 |
2018-05-03 |
Bioelectron Technology Corporation |
Methods of analyzing p-hydroquinone levels and ratios
|
|
WO2018093957A1
(en)
|
2016-11-15 |
2018-05-24 |
Bioelectron Technology Corporation |
2-substituted amino-naphth[1,2-d]imidazol-5-one compounds or pharmaceutically acceptable salts thereof cross reference to related applications
|
|
JP2018083799A
(ja)
|
2016-11-15 |
2018-05-31 |
バイオエレクトロン テクノロジー コーポレイション |
２−置換アミノ−ナフト［１，２−ｄ］イミダゾール−５−オン化合物またはその製薬学上許容される塩
|
|
WO2018129411A1
(en)
|
2017-01-06 |
2018-07-12 |
Bioelectron Technology Corporation |
Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
|
|
WO2018191732A1
(en)
|
2017-04-14 |
2018-10-18 |
Bioelectron Technology Corporation |
Methods and compositions for treatment of inflammation and oxidative stress
|
|
US20180333389A1
(en)
|
2017-04-14 |
2018-11-22 |
Bioelectron Technology Corporation |
Vitamin e compositions and methods of use therefor
|